Richard Mark Watson

7832920, Nov 16, 2010

Oct 25, 2007

11/924589

Anthony B. Wood - Dallas TX, US
Gregory J. Archambeau - Puyallap WA, US
Richard L. Watson - McPherson KS, US

Revalesio Corporation - Tacoma WA

B01F 7/12

3661703, 3661711, 3661721, 366305

A mixing device for mixing a first and second material together to create an output mixture. The device includes a first chamber containing the first material coupled to a mixing chamber defined between a rotor and a stator. The rotor is disposed inside the stator and rotates therein about an axis of rotation. The first chamber houses an internal pump configured to pump the first material from the first chamber into the mixing chamber. The pump may be configured to impart a circumferential velocity into the first material before it enters the mixing chamber. At least one of the rotor and stator have a plurality of through-holes through which the second material is provided to the mixing chamber. Optionally, a second chamber is coupled to the mixing chamber. The second chamber may house an internal pump configured to pump the output material from the mixing chamber into the second chamber.

7919534, Apr 5, 2011

Oct 25, 2007

11/924595

Anthony B. Wood - Dallas TX, US
Gregory J. Archambeau - Puyallap WA, US
Richard L. Watson - McPherson KS, US

Revalesio Corporation - Tacoma WA

B01F 3/04

516 10, 3661524

Particular aspects provide compositions comprising an electrokinetically altered oxygenated aqueous fluid, wherein the oxygen in the fluid is present in an amount of at least 25 ppm. In certain aspects, the electrokinetically altered oxygenated aqueous fluid comprises electrokinetically modified or charged oxygen species present in an amount of at least 0. 5 ppm. In certain aspects the electrokinetically altered oxygenated aqueous fluid comprises solvated electrons stabilized by molecular oxygen, and wherein the solvated electrons present in an amount of at least 0. 01 ppm. In certain aspects, the fluid facilitates oxidation of pyrogallol to purpurogallin in the presence of horseradish peroxidase enzyme (HRP) in an amount above that afforded by a control pressure pot generated or fine-bubble generated aqueous fluid having an equivalent dissolved oxygen level, and wherein there is no hydrogen peroxide, or less than 0. 1 ppm of hydrogen peroxide present in the electrokinetic oxygen-enriched aqueous fluid.

8410182, Apr 2, 2013

Apr 30, 2009

12/433741

Anthony B. Wood - Dallas TX, US
Gregory J. Archambeau - Puyallap WA, US
Richard L. Watson - McPherson KS, US

Revalesio Corporation - Tacoma WA

B01F 3/04
C02F 1/46

516 10, 204221, 204468, 977837

Provided are electrokinetically-altered fluids (e. g. , gas-enriched (e. g. , oxygen-enriched) electrokinetic fluids) comprising an ionic aqueous solution of charge-stabilized oxygen-containing nanostructures in an amount sufficient to provide, upon contact with a cell, modulation of at least one of cellular membrane potential and cellular membrane conductivity. Further provided are the methods of making the electrokinetically-altered ionic aqueous fluid compositions. Particular aspects provide for regulating or modulating intracellular signal transduction associated by modulation of at least one of cellular membranes, membrane potential, membrane proteins such as membrane receptors, including but not limited to G-Protein Coupled Receptors (GPCR), and intercellular junctions (e. g. , tight junctions, gap junctions, zona adherins and desmasomes). Other embodiments include particular methods of producing the electrokinetically-altered fluids.

8445546, May 21, 2013

May 4, 2010

12/773825

Anthony B. Wood - Dallas TX, US
Richard L. Watson - McPherson KS, US
Gregory J. Archambeau - Puyallup WA, US

Revalesio Corporation - Tacoma WA

B01F 3/04

516 10

Provided are electrokinetically-altered fluids (e. g. , gas-enriched (e. g. , oxygen-enriched) electrokinetic fluids) comprising an ionic aqueous solution of charge-stabilized gas-containing nanostructures in an amount sufficient to provide, upon contact with a cell, modulation of at least one of cellular membrane potential and cellular membrane conductivity. Further provided are the methods of making the electrokinetically-altered ionic aqueous fluid compositions. Particular aspects provide for regulating or modulating intracellular signal transduction associated by modulation of at least one of cellular membranes, membrane potential, membrane proteins such as membrane receptors, including but not limited to G-Protein Coupled Receptors (GPCR), and intercellular junctions (e. g. , tight junctions, gap junctions, zona adherins and desmasomes). Other embodiments include particular methods of producing the electrokinetically-altered fluids.

8449172, May 28, 2013

Nov 12, 2010

12/945703

Anthony B. Wood - Dallas TX, US
Gregory J. Archambeau - Puyallup WA, US
Richard L. Watson - McPherson KS, US

Revalesio Corporation - Tacoma WA

B01F 7/12

3661703, 3661711, 3661721, 366305

A mixing device for mixing a first and second material together to create an output mixture. The device includes a first chamber containing the first material coupled to a mixing chamber defined between a rotor and a stator. The rotor is disposed inside the stator and rotates therein about an axis of rotation. The first chamber houses an internal pump configured to pump the first material from the first chamber into the mixing chamber. The pump may be configured to impart a circumferential velocity into the first material before it enters the mixing chamber. At least one of the rotor and stator have a plurality of through-holes through which the second material is provided to the mixing chamber. Optionally, a second chamber is coupled to the mixing chamber. The second chamber may house an internal pump configured to pump the output material from the mixing chamber into the second chamber.

8470893, Jun 25, 2013

Jan 28, 2011

13/016659

Anthony B. Wood - Dallas TX, US
Gregory J. Archambeau - Puyallup WA, US
Richard L. Watson - McPherson KS, US

Revalesio Corporation - Tacoma WA

B01F 3/04

516 10

Particular aspects provide compositions comprising an electrokinetically altered oxygenated aqueous fluid, wherein the oxygen in the fluid is present in an amount of at least 25 ppm. In certain aspects, the electrokinetically altered oxygenated aqueous fluid comprises electrokinetically modified or charged oxygen species present in an amount of at least 0. 5 ppm. In certain aspects the electrokinetically altered oxygenated aqueous fluid comprises solvated electrons stabilized by molecular oxygen, and wherein the solvated electrons present in an amount of at least 0. 01 ppm. In certain aspects, the fluid facilitates oxidation of pyrogallol to purpurogallin in the presence of horseradish peroxidase enzyme (HRP) in an amount above that afforded by a control pressure pot generated or fine-bubble generated aqueous fluid having an equivalent dissolved oxygen level, and wherein there is no hydrogen peroxide, or less than 0. 1 ppm of hydrogen peroxide present in the electrokinetic oxygen-enriched aqueous fluid.

8591957, Nov 26, 2013

Oct 25, 2007

11/924601

Gregory J. Archambeau - Puyallap WA, US
Anthony B. Wood - Dallas TX, US
Richard L. Watson - McPherson KS, US

Revalesio Corporation - Tacoma WA

A01N 39/00

424613

Particular embodiments disclosed herein relate to electrokinetically altered gas-enriched fluids, methods of making the same, systems for making the same and/or methods of treatment utilizing the gas-enriched fluids for eye related conditions and/or diseases. In certain embodiments, the electrokinetically altered gas-enriched fluid is oxygen-enriched water. Certain embodiments relate to cosmetic and/or therapeutic fluids and/or methods of treatment utilizing the fluids to treat a cosmetic and/or therapeutic symptom related to eye conditions and/or diseases.

8609148, Dec 17, 2013

Apr 28, 2009

12/431577

Gregory J. Archambeau - Puyallap WA, US
Anthony B. Wood - Dallas TX, US
Richard L. Watson - McPherson KS, US

Revalesio Corporation - Tacoma WA

A01N 39/00

424613

Provided are electrokinetically-altered aqueous fluids (e. g. , gas-enriched electrokinetic fluids) comprising an ionic aqueous solution of charge-stabilized oxygen-containing nanostructures in an amount sufficient to provide modulation of at least one of cellular membrane potential and cellular membrane conductivity, and therapeutic compositions and methods for use in treating an irritation, infection or inflammatory eye condition, comprising administering to, by contacting the eye of a subject in need thereof a therapeutically effective amount of an electrokinetically-altered aqueous fluid. The electrokinetically-altered fluids or therapeutic compositions and methods include electrokinetically-altered ioinic aqueous fluids optionally in combination with other therapeutic agents. Other embodiments include particular routes of administration or formulations for the electrokinetically-altered fluids (e. g. , electrokinetically-altered gas-enriched fluids) and therapeutic compositions for use in treating eye conditions.